Benzinga | Apr 7, 2021 08:01AM EDT

Astrotech Subsidiary And Cleveland Clinic Sign Agreement For Breath Analysis Study To Develop A Rapid COVID-19 Breath Test

Astrotech Corporation's (NASDAQ:ASTC) subsidiary, BreathTech Corporation announced today that it has signed an Investigator-Initiated Study Agreement with the Cleveland Clinic Foundation (Cleveland Clinic). Under this agreement, BreathTech's BreathTest-1000(tm) will be used to compare exhaled breath from individuals who have tested positive on a COVID-19 polymerase chain reaction (PCR) test with that from subjects who have had a negative COVID-19 PCR test. The goal of the pilot study will be to analyze different volatile organic compounds (VOCs) from the breath to evaluate the correlation with different disease states.